Literature DB >> 18003887

Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses.

Tony J Kenna1, Ranjeny Thomas, Raymond J Steptoe.   

Abstract

Antigen stimulation of naive T cells in conjunction with strong costimulatory signals elicits the generation of effector and memory populations. Such terminal differentiation transforms naive T cells capable of differentiating along several terminal pathways in response to pertinent environmental cues into cells that have lost developmental plasticity and exhibit heightened responsiveness. Because these cells exhibit little or no need for the strong costimulatory signals required for full activation of naive T cells, it is generally considered memory and effector T cells are released from the capacity to be inactivated. Here, we show that steady-state dendritic cells constitutively presenting an endogenously expressed antigen inactivate fully differentiated memory and effector CD8(+) T cells in vivo through deletion and inactivation. These findings indicate that fully differentiated effector and memory T cells exhibit a previously unappreciated level of plasticity and provide insight into how memory and effector T-cell populations may be regulated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18003887     DOI: 10.1182/blood-2007-07-103200

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

Review 1.  Regulatory dendritic cells for human organ transplantation.

Authors:  Angus W Thomson; Diana M Metes; Mohamed B Ezzelarab; Dalia Raïch-Regué
Journal:  Transplant Rev (Orlando)       Date:  2019-05-13       Impact factor: 3.943

2.  Distinct mechanisms mediate naive and memory CD8 T-cell tolerance.

Authors:  Evan R Jellison; Michael J Turner; David A Blair; Elizabeth G Lingenheld; Li Zu; Lynn Puddington; Leo Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

3.  Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells.

Authors:  M B Ezzelarab; D Raich-Regue; L Lu; A F Zahorchak; A Perez-Gutierrez; A Humar; M Wijkstrom; M Minervini; R W Wiseman; D K C Cooper; A E Morelli; A W Thomson
Journal:  Am J Transplant       Date:  2017-02-02       Impact factor: 8.086

4.  Th2 cells lacking T-bet suppress naive and memory T cell responses via IL-10.

Authors:  Melba Muñoz; Ahmed N Hegazy; Tobias M Brunner; Vivien Holecska; Roman M Marek; Anja Fröhlich; Max Löhning
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

Review 5.  Tolerogenic dendritic cells and their role in transplantation.

Authors:  Mohamed Ezzelarab; Angus W Thomson
Journal:  Semin Immunol       Date:  2011-07-07       Impact factor: 11.130

6.  A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin.

Authors:  Salvatore Fiorenza; Tony J Kenna; Iain Comerford; Shaun McColl; Raymond J Steptoe; Graham R Leggatt; Ian H Frazer
Journal:  J Immunol       Date:  2012-11-09       Impact factor: 5.422

7.  High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation.

Authors:  Alan F Zahorchak; Camila Macedo; David E Hamm; Lisa H Butterfield; Diana M Metes; Angus W Thomson
Journal:  Cell Immunol       Date:  2017-09-14       Impact factor: 4.868

Review 8.  Tolerogenic dendritic cells: all present and correct?

Authors:  A W Thomson
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

9.  Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance.

Authors:  Angus W Thomson; Hēth R Turnquist; Alan F Zahorchak; Giorgio Raimondi
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

10.  Dendritic cell therapy in composite tissue allotransplantation.

Authors:  A W Thomson; J M Sacks; Y-R Kuo; R Ikeguchi; E K Horibe; J Unadkat; M G Solari; M Feili-Hariri; W P A Lee
Journal:  Transplant Proc       Date:  2009-03       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.